Fig. 2From: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human gliomaSurvival analyses of cancer patients based on expression of MYBL2 and FoxM1. a Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower-expression-level in 79 glioma tissues. b Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower expression levels in LGG. c Associations between MYBL2 (left) and FoxM1 (right) gene expression levels and disease-free survival in LGG. d Compare overall survival time between MYBL2 (left) or FoxM1 (right) higher expression levels and lower-expression-level in HGG. e Associations between MYBL2 (left) and FoxM1 (right) gene expression levels and disease-free survival in HGGBack to article page